Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.88 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.48 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | DHODH | Q02127 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30548734 | 1.00 | ALDH1A1 (0.88) | ALDH1A1ALOX15NR4A1NR4A2NR4A3 | |
| Phenazine-1-Carboxylic Acid SCHEMBL27884214 | 0.94 | ALDH1A1 (1.00) | ALDH1A1ALOX15NR4A1NR4A2NR4A3 | |
| Phenazine-1-Carboxylic Acid SCHEMBL28160016 | 0.94 | ALDH1A1 (1.00) | ALDH1A1ALOX15NR4A1NR4A2NR4A3 | |
| Phenazine-1-Carboxylic Acid SCHEMBL29370801 | 0.94 | ALDH1A1 (1.00) | ALDH1A1ALOX15NR4A1NR4A2NR4A3 | |
| Phenazine-1-Carboxylic Acid SCHEMBL122864 | 0.94 | ALDH1A1 (1.00) | ALDH1A1ALOX15NR4A1NR4A2NR4A3 | |
| Phenazine-1-Carboxylic Acid SCHEMBL28714733 | 0.92 | ALDH1A1 (0.96) | ALDH1A1ALOX15NR4A1NR4A2NR4A3 | |
| SCHEMBL19971558 | 0.90 | ALDH1A1 (0.73) | ALDH1A1ALOX15NR4A1NR4A2NR4A3 | |
| Phenazine-1-Carboxylic Acid SCHEMBL27752237 | 0.90 | ALDH1A1 (0.93) | ALDH1A1ALOX15NR4A1NR4A2NR4A3 | |
| SCHEMBL3193693 | 0.90 | ALDH1A1 (0.73) | ALDH1A1ACHEKDM4ERAB9AMAPT | |
| SCHEMBL5448034 | 0.89 | ALDH1A1 (0.71) | ALDH1A1KDM4ERAB9AHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117778280-A | Chassis strain suitable for heterologous biosynthesis of antibacterial material myxin, construction method and application thereof | 江苏省农业科学院 | 2024-03-29 | — | — | CN | claimed |
| CN-116656713-A | Application of phzB-G gene in synthesis of phenazine-1, 6-dicarboxylic acid | 上海交通大学 | 2023-08-29 | — | — | CN | claimed |
| US-20190048354-A1 | PATHWAY INTEGRATION AND EXPRESSION IN HOST CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-02-14 | — | — | US | claimed |
| WO-2017176347-A9 | PATHWAY INTEGRATION AND EXPRESSION IN HOST CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORINIA (US) | 2017-11-09 | — | — | WO | claimed |
| WO-2017176347-A2 | PATHWAY INTEGRATION AND EXPRESSION IN HOST CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORINIA (US) | 2017-10-12 | — | — | WO | claimed |
| EP-4022047-B1 | IMPROVED POLYPEPTIDES CAPABLE OF CONVERTING SUBSTRATE 3-KETO- DEOXYNIVALENOL INTO 3-EPI- DEOXYNIVALENOL | DSM Austria GmbH (AT) | 2026-04-22 | — | — | EP | disclosed |
| EP-4631530-A1 | STERILIZATION METHOD AND COMPOSITION USED IN STERILIZATION METHOD | National Institute for Materials Science (JP) | 2025-10-15 | — | — | EP | disclosed |
| US-20250228880-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-07-17 | — | — | US | disclosed |
| EP-3273802-B1 | USE OF A TRICHOTHECENE-TRANSFORMING ALCOHOL DEHYDROGENASE, METHOD FOR TRANSFORMING TRICHOTHECENES AND TRICHOTHECENE-TRANSFORMING ADDITIVE | DSM Austria GmbH (AT) | 2025-06-25 | — | — | EP | disclosed |
| CN-112442489-B | Improved polypeptides for converting substrate 3-keto-deoxynivalenol to 3-epi-deoxynivalenol | 爱尔伯股份公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-117778280-A | Chassis strain suitable for heterologous biosynthesis of antibacterial material myxin, construction method and application thereof | 江苏省农业科学院 | 2024-03-29 | — | — | CN | disclosed |
| US-11820973-B2 | Methods and system for interfering with viability of bacteria and related compounds and compositions | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2023-11-21 | — | — | US | disclosed |
| US-5723759-A | ANTIPATHOGENIC SUBSTANCE | NOVARTIS FINANCE CORPORATION (US) | 1998-03-03 | — | — | US | disclosed |
| US-5698425-A | TRANSFORMING PLANT TO PRODUCE PYRROLNITRIN | NOVARTIS FINANCE CORPORATION (US) | 1997-12-16 | — | — | US | disclosed |
| US-5679560-A | ENZYME REQUIRED IN BIOSYNTHETIC PATHWAY OF PYRROLNITRIN; PROTECTION OF PLANTS AGAINST PHYTOPATHOGENS | NOVARTIS FINANCE CORPORATION (US) | 1997-10-21 | — | — | US | disclosed |
| US-5662898-A | Genes for the synthesis of antipathogenic substances | CIBA-GEIGY CORPORATION (US) | 1997-09-02 | — | — | US | disclosed |
| US-5643774-A | DNA MOLECULES WITH POLYPEPTIDES FORMED BY BIOSYNTHESIS | CIBA-GEIGY CORPORATION (US) | 1997-07-01 | — | — | US | disclosed |
| US-5639949-A | DNA MOLECULE ENCODING ONE OR MORE POLYPEPTIDES REQUIRED FOR THE BIOSYNTHESIS OF PYRROLNITRIN | CIBA-GEIGY CORPORATION (US) | 1997-06-17 | — | — | US | disclosed |
| EP-0759078-A1 | GENES FOR THE SYNTHESIS OF ANTIPATHOGENIC SUBSTANCES | Novartis AG (CH) | 1997-02-26 | — | — | EP | disclosed |
| WO-1995033818-A2 | GENES FOR THE SYNTHESIS OF ANTIPATHOGENIC SUBSTANCES | CIBA-GEIGY AG (CH) | 1995-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228880-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | TXN2, SQOR, LPO | ALDH1A1 720/4885ALOX15 257/4885NR4A1 2853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.